Seelos Therapeutics's total assets for Q2 2023 were $11.85M, a decrease of -49.98% from the previous quarter. DE:NXEN total liabilities were $59.07M for the fiscal quarter, a 33.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.